{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:55:42Z","timestamp":1790621742755,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18ek0109400"],"award-info":[{"award-number":["JP18ek0109400"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jid.2023.05.021","type":"journal-article","created":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T09:01:59Z","timestamp":1686387719000},"page":"2447-2455.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Gene-Modified Blister Fluid\u2013Derived Mesenchymal Stromal Cells for Treating Recessive Dystrophic Epidermolysis Bullosa"],"prefix":"10.1016","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8820-2886","authenticated-orcid":false,"given":"Yasushi","family":"Kikuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3423-0683","authenticated-orcid":false,"given":"Tomoki","family":"Tamakoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1012-2784","authenticated-orcid":false,"given":"Ryuichi","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1278-6480","authenticated-orcid":false,"given":"Ryosuke","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6135-1881","authenticated-orcid":false,"given":"Shiho","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3104-102X","authenticated-orcid":false,"given":"Akemi","family":"Ishida-Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3062-4872","authenticated-orcid":false,"given":"Manabu","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6106-5434","authenticated-orcid":false,"given":"Yasufumi","family":"Kaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0953-7157","authenticated-orcid":false,"given":"Katsuto","family":"Tamai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2023.05.021_bib1","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.jid.2017.07.002","article-title":"Pro-inflammatory chemokines and cytokines dominate the blister fluid molecular signature in patients with epidermolysis bullosa and affect leukocyte and stem cell migration","volume":"137","author":"Alexeev","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.05.021_bib2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3109\/14653241003587637","article-title":"Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa","volume":"12","author":"Conget","year":"2010","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jid.2023.05.021_bib3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jid.2023.05.021_bib4","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.130554","article-title":"Phase 1\/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa","volume":"4","author":"Eichstadt","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jid.2023.05.021_bib5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jaad.2008.09.035","article-title":"Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986\u20132006","volume":"60","author":"Fine","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2023.05.021_bib6","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1016\/j.jid.2018.04.028","article-title":"Intradermal injection of bone marrow mesenchymal stromal cells corrects recessive dystrophic epidermolysis bullosa in a xenograft model","volume":"138","author":"Ganier","year":"2018","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.05.021_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230392","article-title":"High-mobility group box 1 fragment suppresses adverse post-infarction remodeling by recruiting PDGFRa-positive bone marrow cells","volume":"15","author":"Goto","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2023.05.021_bib8","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s41591-022-01737-y","article-title":"In\u00a0vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial","volume":"28","author":"Gurevich","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2023.05.021_bib9","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41591-018-0049-z","article-title":"CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response","volume":"24","author":"Haapaniemi","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2023.05.021_bib10","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1242\/jcs.112.21.3641","article-title":"Targeted inactivation of the type VII collagen gene (Col7a1) in mice results in severe blistering phenotype: a model for recessive dystrophic epidermolysis bullosa","volume":"112","author":"Heinonen","year":"1999","journal-title":"J\u00a0Cell Sci"},{"key":"10.1016\/j.jid.2023.05.021_bib11","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nbt.1562","article-title":"Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases","volume":"27","author":"Hockemeyer","year":"2009","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jid.2023.05.021_bib12","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/s41591-018-0050-6","article-title":"p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells","volume":"24","author":"Ihry","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2023.05.021_bib13","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/hepr.13825","article-title":"Synthesized HMGB1 peptide prevents the progression of inflammation, steatosis, fibrosis, and tumor occurrence in a non-alcoholic steatohepatitis mouse model","volume":"52","author":"Ishii","year":"2022","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jid.2023.05.021_bib14","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/mt.2009.144","article-title":"Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity","volume":"17","author":"Kern","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.jid.2023.05.021_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202838","article-title":"The administration of high-mobility group box 1 fragment prevents deterioration of cardiac performance by enhancement of bone marrow mesenchymal stem cell homing in the delta-sarcoglycan-deficient hamster","volume":"13","author":"Kido","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2023.05.021_bib16","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/jbm.a.36627","article-title":"Cell sheet tissue engineering: cell sheet preparation, harvesting\/manipulation, and transplantation","volume":"107","author":"Kobayashi","year":"2019","journal-title":"J\u00a0Biomed Mater Res A"},{"key":"10.1016\/j.jid.2023.05.021_bib17","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nbt.4192","article-title":"Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements","volume":"36","author":"Kosicki","year":"2018","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jid.2023.05.021_bib18","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1002\/j.1460-2075.1992.tb05614.x","article-title":"Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination","volume":"11","author":"Kotin","year":"1992","journal-title":"EMBO J"},{"key":"10.1016\/j.jid.2023.05.021_bib19","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1038\/mt.2015.58","article-title":"High local concentrations of intradermal MSCs restore skin integrity and facilitate wound healing in dystrophic epidermolysis bullosa","volume":"23","author":"K\u00fchl","year":"2015","journal-title":"Mol Ther"},{"key":"10.1016\/j.jid.2023.05.021_bib20","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.143606","article-title":"Intravenous allogeneic umbilical cord blood-derived mesenchymal stem cell therapy in recessive\u00a0dystrophic epidermolysis bullosa patients","volume":"6","author":"Lee","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.jid.2023.05.021_bib21","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fcell.2020.00258","article-title":"Senescence in mesenchymal stem cells: functional alterations, molecular mechanisms, and rejuvenation strategies","volume":"8","author":"Liu","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jid.2023.05.021_bib22","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.126243","article-title":"Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosa","volume":"4","author":"Lwin","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jid.2023.05.021_bib23","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.jid.2018.11.036","article-title":"Gene therapy for epidermolysis bullosa","volume":"139","author":"Marinkovich","year":"2019","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.05.021_bib24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s13287-019-1431-6","article-title":"Phenotypic traits of mesenchymal stem cell sheets fabricated by temperature-responsive cell culture plate: structural characteristics of MSC sheets","volume":"10","author":"Nakao","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jid.2023.05.021_bib25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s41232-021-00177-4","article-title":"Synthesized HMGB1 peptide attenuates liver inflammation and suppresses fibrosis in mice","volume":"41","author":"Nojiri","year":"2021","journal-title":"Inflamm Regen"},{"key":"10.1016\/j.jid.2023.05.021_bib26","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1038\/jid.2015.158","article-title":"Potential of systemic allogeneic mesenchymal stromal cell therapy for children with recessive dystrophic epidermolysis bullosa","volume":"135","author":"Petrof","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.05.021_bib27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jid.2019.05.031","article-title":"Human mesenchymal stromal cells engineered to express collagen VII can restore anchoring fibrils in recessive dystrophic epidermolysis bullosa skin graft chimeras","volume":"140","author":"Petrova","year":"2020","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.05.021_bib28","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jaad.2019.11.038","article-title":"Phase I\/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa","volume":"83","author":"Rashidghamat","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2023.05.021_bib29","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1089\/ten.tea.2010.0659","article-title":"Cardiac cell sheet transplantation improves damaged heart function via superior cell survival in comparison with dissociated cell injection","volume":"17","author":"Sekine","year":"2011","journal-title":"Tissue Eng Part A"},{"key":"10.1016\/j.jid.2023.05.021_bib30","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1634\/stemcells.2007-0039","article-title":"Robust, persistent transgene expression in human embryonic stem cells is\u00a0achieved with AAVS1-targeted integration","volume":"26","author":"Smith","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.jid.2023.05.021_bib31","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/bjd.20910","article-title":"The potential of gene therapy for recessive dystrophic epidermolysis bullosa","volume":"186","author":"Subramaniam","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2023.05.021_bib32","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1073\/pnas.1016753108","article-title":"PDGFR\u03b1-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia","volume":"108","author":"Tamai","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2023.05.021_bib33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0022-1759(90)90396-D","article-title":"Alkaline phosphatase-fast red, a new fluorescent label. Application in double labelling for cell cycle analysis","volume":"132","author":"Murdoch","year":"1990","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.jid.2023.05.021_bib34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ymeth.2015.12.012","article-title":"Engineering the AAVS1 locus for consistent and scalable transgene expression in human iPSCs and their differentiated derivatives","volume":"101","author":"Oceguera-Yanez","year":"2016","journal-title":"Methods"},{"key":"10.1016\/j.jid.2023.05.021_bib35","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.aad5227","article-title":"Rationally engineered Cas9 nucleases with improved specificity","volume":"351","author":"Slaymaker","year":"2016","journal-title":"Science"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X23023321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X23023321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:53:00Z","timestamp":1762206780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X23023321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0022202X23023321"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2023.05.021","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene-Modified Blister Fluid\u2013Derived Mesenchymal Stromal Cells for Treating Recessive Dystrophic Epidermolysis Bullosa","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2023.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}